https://www.avient.com/sites/default/files/resources/POL%2520BofA%2520Basic%2520Materials%2520IR%2520Presentation%2520w%2520non-GAAP%252012%252011%25202013.pdf
Use of Non-GAAP Measures
Page 3
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500
All time high of
$34.47
December 9th, 2013
• 16 consecutive quarters of
double digit EPS growth
• 42% CAGR adjusted EPS
expansion 2006-2012
• YTD stock price has increased
63% versus 27% growth in the
S&P
• More than six fold increase in
market cap: $0.5b $3.3b
Strategy and Execution Drive Results
Page 4
The World’s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Four Pillar Strategy
Page 5
PP&S
15%
Specialty
60%
Distribution
25%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010* 2011* 2012* 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
Appliance
6%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
4%
Consumer
9%
Packaging
18%
Industrial
10%
Misc.
5%
HealthCare
9%
Transportation
16%
Textiles
1%
United
States
70%
Europe
14%
Canada
8%
Asia
5%
Latin
America
3%
2012 Revenues: $4.0 Billion*
End Markets*
2012 Revenues: $4.0 Billion*
EPS
Page 6
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations
PolyOne
At A Glance
* Restated to exclude discontinued operations
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34%
43%
63%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 YTD 2013 2015
%
o
f O
pe
ra
ti
ng
In
co
m
e*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $87M $153M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 YTD 2013 2015
Where we were Where we are
Organic Consolidated
Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.8% 12.8% 12 – 16%
Global Specialty Engineered
Materials 1.1% 10.8% 8.9% 12 – 16%
Designed Structures & Solutions — — 5.0% 8 – 10%
Performance Products &
Solutions 5.5% 8.0% 8.2% 9 – 12%
Distribution 2.6% 6.1% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 63% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.4% 15%
4) Adjusted EPS Growth N/A 28%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
*Percentage of Specialty Platform revenue from products introduced in last five years
19.5%
44.0%
2006 Q3 2013
$20.3
$46.6
2006 TTM
Q3'13
14.3%
31.0%
2006 Q3 2013
Research & Development
Spending
Specialty Platform
Vitality Index Progression*
Innovation Drives Earnings Growth
($ millions)
Specialty Platform
Gross Margin %
Page 9
We are Experts in Polymer Science and Formulation
Polymer Science
Formulation
Chemistry
Processing
Inputs
Base Resins
Additives
Modifiers
Colorants
Specialized
Polymer Materials,
Services, and Solutions
Expertise
Satisfied
Consumers
PolyOne Customer
Innovative
Products & Services
Marketplace Demands
Performance Requirements
Value Drivers
Page 10
Positioned for Strong Growth
2015 Target
Rev: $5B
Adj.
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_elastomers_for_overmolding_applications.pdf
Optimal adhesion values are also obtained for
overmolds onto PC (Lexan), ABS (Cycoloy), PC/ABS(Cycolac) and PC/PBT (Xenoy) as demonstrated in Figure
5.
This good bonding performance was observed within a wide range of melt processing temperatures as shown
in Figure.5.
olycarbonate derived from Bisphenol A (PC) - Totally Amorphous P
oly(acrylonitrile-co-butadiene-styrene) (ABS – 15%-35%AN,5-30%BD,40-60%ST) – Totally amorphous P
C*
Acetal Homopolymer – 98% crystalline
Acetal Copolymer
igure 4.
https://www.avient.com/sites/default/files/2025-02/Hammerhead FR Panel eBook.pdf
According to a
McKinsey & Company report, modular projects:
• have established a solid track record of accelerating project timelines by
20 to 50%
• can deliver over 20% in construction cost savings when optimized for scale
In a survey conducted by Prefab Modular Smart Market Report (2020):
• 91% of contractors reported improved budget performance when using
modular techniques
• 68% of these indicated savings of 5% or higher
• respondents indicated reductions in project durations of 20 to 50%
Another factor—the well-publicized shortage of available and affordable housing
stock—is also contributing to the rise of modular construction, particularly in
urban areas with high demand and limited space.
Many contractors
report improved
budget outcomes
with modular
techniques
Modular methods
shorten project
timelines by 20–50%
PROJECT
TYPES
Benefits of Modular Construction
BUDGET
PERFORMANCE
COST
REDUCTION
Multifamily, commercial,
and healthcare
construction projects
are increasingly
using modular
techniques
Contractors
see cost savings
over 5% from
modular construction
PROJECT
DURATION
MARKET DYNAMICS
Source: Avient
Modular and off-site construction projects demand materials that do more:
streamline projects without sacrificing performance.
Modular construction: From projects to products (2019)
• Avient internal data (November 2024)
• Composites World, “Composite SIPs for more affordable, efficient and sustainable buildings,”
October 21, 2024
• US Census Bureau, HUD, October 19, 2024
Next Page 14:
Previous Page 15:
Previous Page 27:
Next Page 16:
Previous Page 17:
Next Page 17:
Previous Page 18:
Next Page 5:
Previous Page 5:
Next Page 18:
Previous Page 19:
Next Page 19:
Previous Page 20:
Next Page 20:
Previous Page 21:
Next Page 21:
Previous Page 22:
Next Page 22:
Previous Page 23:
Next Page 15:
Previous Page 16:
Next Page 23:
Previous Page 24:
Next Page 24:
Previous Page 25:
Next Page 25:
Previous Page 26:
Next Page 26:
Next Page 27:
Previous Page 28:
Next Page 28:
https://www.avient.com/sites/default/files/2021-06/escritura-publica-cambio-razon-social-performance-masterbatches618442v1.pdf
www.fojas.cl
Pag: 1/1
Pag: 1/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 2/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 3/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 4/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 5/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 6/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 7/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 8/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 9/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 10/11
Certificado Nº
123456880196
Verifique validez en
http://www.fojas.cl
Pag: 11/11
2021-05-31T12:52:48-0400
Santiago - Chile
EDUARDO JAVIER DIEZ MORELLO
Notario Publico Eduardo_Diez_Morello
https://www.avient.com/sites/default/files/2024-12/ISO 14001_Chinese_Changzhou.pdf
环境管理体系认证
证书编号:04624E12884R1S
兹证明:
法博莱恩纱线(常州)有限公司
统一社会信用代码:91320412MA1NMF5W4P
环境管理体系符合:
GB/T 24001-2016 / ISO 14001:2015 标准
证书覆盖范围:
纺织品(纱线)、玻璃制品(纱线)的包覆加工及相关管
理活动
注册地址/实际地理地址:江苏省常州西太湖科技产业园兰香路 8 号研发车间
5 厂房
颁证日期:2024-10-26
有效期至:2027-10-25
初次颁证日期:2021-10-28
证书编号
受审核方
组织机构代码
认证范围
注册地址
生产办公地址
注册日期
有效期至
初次颁证日期
二维码
https://www.avient.com/content/terms-conditions-carriage
5.
https://www.avient.com/products/advanced-composites/continuous-fiber-composite-tape-laminates-and-barstock/polystrand-continuous-fiber-tapes-laminates
5
https://www.avient.com/sites/default/files/2023-12/Versaflex OM TPEs for Sealing Ring of Blood Lancet.pdf
BLOOD LANCET
MANUFACTURER
S E A L I N G R I N G
• Compliance with strict regulations for medical materials
• Excellent sealing performance
• Good compression set
• Provided a recycled TPE solutions
compared to silicone without increasing
system cost
• Delivered a TPE that complied with ISO
10993-4 & -5 and USP Class VI
• Supported a change to an injection molded
material to ease production and enhance
assembly capabilities
Versaflex™ HC TPEs – OM1040-1 Grade
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2023-11/Versaflex HC -Syringe tip cap-Case study snapshot.pdf
PRE-FILLED
SYRINGE COMPANY
S Y R I N G E T I P C A P
• Excellent sealing performance
• No DEHP or natural rubber latex added during processing
• Can be sterilized by EtO
• Compliant with ISO 10993-4&5 and USP Class VI
• Formulated a solution that met rigorous
medical application requirements
• Leveraged global footprint to ensure supply
continuity
• Increased process efficiency by replacing
previous thermoset material with a TPE
Versaflex™ HC Thermoplastic Elastomers
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2021-08/20210802-certificate-of-incorporation.pdf
POLYONE SINGAPORE PTE LTD 12/04/2001
(Note: Only the five (5) most recent former names are listed.